Hollow Mesoporous Bi@PEG-FA Nanoshell as a Novel Dual-Stimuli-Responsive Nanocarrier for Synergistic Chemo-Photothermal Cancer Therapy

ACS Appl Mater Interfaces. 2020 Jul 15;12(28):31172-31181. doi: 10.1021/acsami.0c07372. Epub 2020 Jun 29.

Abstract

The development of stimuli-responsive multifunctional nanocarriers for therapeutic drug delivery is extremely desirable for highly specific treatment of disease. Herein, thiol-polyethylene glycol-folate acid-modified hollow mesoporous bismuth nanoshells (HM-Bi@PEG-FA NSs) were developed as the new dual-stimuli-responsive single-"elemental" photothermal nanocarriers for synergistic chemo-photothermal therapy of tumor. The designed hollow-mesoporous-type nanocarriers present excellent photothermal conversion capacity (∼34.72%) and good biocompatibility. Meanwhile, acidic pH and near-infrared (NIR) laser dual-stimulated doxorubicin (DOX) release is successfully achieved. More importantly, the DOX-loaded HM-Bi@PEG-FA NSs hold an efficient in vitro/in vivo antitumor effect through the synergistic chemo-photothermal therapy. Therefore, our findings provide the possibility of designing a dual-stimuli-responsive hollow mesoporous Bi-based photothermal nanocarrier for synergistically enhanced antitumor therapy.

Keywords: bismuth nanoshells; chemo-photothermal therapy; dual-stimuli-responsive; hollow mesoporous structure; photothermal nanocarriers.

MeSH terms

  • Cell Line, Tumor
  • Doxorubicin / chemistry
  • Drug Delivery Systems / methods*
  • Humans
  • Nanoparticles / chemistry
  • Nanoshells / chemistry*
  • Phototherapy / methods

Substances

  • Doxorubicin